Basic information Safety Supplier Related

N6022

Basic information Safety Supplier Related

N6022 Basic information

Product Name:
N6022
Synonyms:
  • N6022
  • 1-[4-(Aminocarbonyl)-2-methylphenyl]-5-[4-(1H-imidazol-1-yl)phenyl]-1H-pyrrole-2-propanoic acid
  • 1-[4-(Aminocarbonyl)-2-methylphenyl]-5-[4-(1H-imidazol-1-yl)phenyl]-1H-pyrrole-2-propanoic acid N 6022
  • N6022, >=98%
  • 3-[1-(4-carbamoyl-2-methylphenyl)-5-(4-imidazol-1-ylphenyl)pyrrol-2-yl]propanoic acid
  • N 6022; N-6022
  • CS-1460
  • 1H-Pyrrole-2-propanoic acid, 1-[4-(aminocarbonyl)-2-methylphenyl]-5-[4-(1H-imidazol-1-yl)phenyl]-
CAS:
1208315-24-5
MF:
C24H22N4O3
MW:
414.46
Product Categories:
  • Inhibitors
Mol File:
1208315-24-5.mol
More
Less

N6022 Chemical Properties

Boiling point:
662.7±55.0 °C(Predicted)
Density 
1.30±0.1 g/cm3(Predicted)
storage temp. 
-20° C
solubility 
Soluble in DMSO (up to at least 25 mg/ml).
form 
solid
pka
4.63±0.10(Predicted)
color 
White
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 2 months.
More
Less

N6022 Usage And Synthesis

Description

N6022 (1208315-24-5) is a potent and reversible inhibitor of S-nitrosoglutathione reductase (GSNOR) – IC50?= 20 nM1, 8 nM2. It demonstrated significant efficacy in mouse models of ovalbumin-induced asthma, chronic obstructive pulmonary disease, and irritable bowel syndrome. N6022 was able to attenuate experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis)?via?selective inhibition of pro-inflammatory CD4+?cells (TH1/TH17) while upregulating anti-inflammatory subsets of CD4+?cells (TH2/Treg) without causing lymphopenia.3

Uses

N6022 is a tight-binding, specific, and fully reversible inhibitor of S-nitrosoglutathione reductase.

in vivo

N6022 (50 mg/kg) treated rats showed a slight increase in the incidence of granulomas. N6022 concentrations in solution were as high as 5 mg/mL in serum[1].

References

[1] XICHENG SUN*. Discovery of S-Nitrosoglutathione Reductase Inhibitors: Potential Agents for the Treatment of Asthma and Other Inflammatory Diseases[J]. ACS Medicinal Chemistry Letters, 2011, 2 5: 402-406. DOI:10.1021/ml200045s
[2] LOUIS S. GREEN. Mechanism of Inhibition for N6022, a First-in-Class Drug Targeting S-Nitrosoglutathione Reductase[J]. Biochemistry Biochemistry, 2012, 51 10: 2157-2168. DOI:10.1021/bi201785u
[3] NISHANT SAXENA . S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis[J]. Free Radical Biology and Medicine, 2018, 121: Pages 57-68. DOI:10.1016/j.freeradbiomed.2018.04.558

N6022Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
Shanghai Taifu Pharmaceutical Technology Co. LTD
Tel
021-58111238 18930958102
Email
sales@taifupharm.com